Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Opt Express ; 22(8): 10026-31, 2014 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-24787884

RESUMO

We report ultraviolet electroluminescence from a hetero p-n junction between a single ZnO microsphere and p-GaN thin film. ZnO microspheres, which have high crystalline quality, have been synthesized by ablating a ZnO sintered target. It was found that synthesized ZnO microspheres had a high-optical property and exhibit the laser action in the whispering gallery mode under pulsed optical pumping. A hetero p-n junction was formed between the single ZnO microsphere/ p-GaN thin film, and a good rectifying property with a turn-on voltage of approximately 6 V was observed in I-V characteristic across the junction. Ultraviolet and visible electroluminescence were observed under forward bias.

2.
Opt Express ; 21(26): 31837-45, 2013 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-24514779

RESUMO

We characterize extreme ultraviolet (EUV) emission from mid-infrared (mid-IR) laser-produced plasmas (LPPs) of the rare-earth element Gd. The energy conversion efficiency (CE) and the spectral purity in the mid-IR LPPs at λL = 10.6 µm were higher than for solid-state LPPs at λL = 1.06 µm, because the plasma produced is optically thin due to the lower critical density, resulting in a CE of 0.7%. The peak wavelength remained fixed at 6.76 nm for all laser intensities studied. Plasma parameters at a mid-IR laser intensity of 1.3×10(11) W/cm(2) was also evaluated by use of the hydrodynamic simulation code to produce the EUV emission at 6.76 nm.

3.
Opt Express ; 20(14): 15247-52, 2012 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-22772222

RESUMO

The effect of the nanosecond laser annealing on the photoluminescence (PL) property of phosphorus ions (P(+)) implanted ZnOnanorods (NRs) has been investigated. The nanosecond laser annealing was performed with the third harmonic of a Q-switched Nd:YAG laser (355nm, 10ns/pulse) at a fluence of 100mJ/cm(2). It turned out that nanosecond laser annealing is more effective in the recovery of the PL property compared with the thermal annealing using an electric furnace. As the results, the I-V characteristics of the p-n homojunctions along ZnO NRs showed rectifying property with a threshold voltage of approximately 6V.

4.
Opt Express ; 19(21): 20389-94, 2011 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-21997048

RESUMO

We report the lasing characteristics of a single ZnO nanosheet optically pumped by ultraviolet laser beam. The ZnO nanosheets were synthesized by a carbothermal chemical vapor deposition method. The ZnO nanosheets dispersed on a silica glass substrate were excited by the third-harmonic of a Q-switched Nd:YAG laser (λ = 355 nm, τ = 5 ns) and photoluminescence from a single ZnO nanosheet was observed. The observed emission spectra showed the obvious lasing characteristics having modal structure and threshold characteristics. The threshold power for lasing was measured to be 50 kW/cm2, which was much lower than 150 kW/cm2, the threshold power of the reference ZnO nanowire. It indicates that the ZnO nanosheet is a superior gain medium for an ultraviolet laser. The oscillation mechanism inside a ZnO nanosheet is attributed to the micro-cavity effect, based on the three-dimensional laser-field simulation.

5.
Nihon Rinsho ; 67(8): 1569-75, 2009 Aug.
Artigo em Japonês | MEDLINE | ID: mdl-19768942

RESUMO

To define and evaluate sleepiness thoroughly has not yet completely established because of its multidimensional aspects of character. Multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT) have been the important tools to assess sleepiness in the research and clinical settings, although they have several limitations and pitfalls. The coverage by the National Health Insurance of MSLT, since April 1, 2008, in Japan, so far not MWT, would extend the diagnosis and care of sleep disorders concerning excessive daytime sleepiness including narcolepsy and idiopathic hypersomnia. The relevant and appropriate use of these modalities should be always considered in line with clinical history, medical information and judgment.


Assuntos
Distúrbios do Sono por Sonolência Excessiva/diagnóstico , Polissonografia/métodos , Humanos , Valor Preditivo dos Testes , Fases do Sono/fisiologia
6.
Diabetes ; 55(6): 1666-77, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16731829

RESUMO

Thiazolidinediones are ligands for peroxisome proliferator-activated receptor (PPAR)-gamma, widely used as insulin sensitizer in type 2 diabetic patients and implicated in apoptosis, cell proliferation, and cell cycle regulation. Here, the effect of thiazolidinediones on G1-phase cell cycle arrest, the hallmark in diabetic nephropathy, was investigated. Eight-week-old male Otsuka Long-Evans Tokushima fatty rats were treated with pioglitazone (1 mg x kg body wt(-1) x day(-1)) until 50 weeks of age and compared with insulin treatment. Although similar HbA(1c) levels were observed in both groups, pioglitazone significantly inhibited glomerular hypertrophy and mesangial matrix expansion and reduced urinary albumin excretion compared with the insulin-treated group. In addition, pioglitazone significantly reduced the number of glomerular p27(Kip1)-positive cells. Because prominent expression of PPAR-gamma was observed in podocytes in glomeruli and cultured cells, conditionally immortalized mouse podocyte cells were cultured under 5.5 and 25 mmol/l D-glucose supplemented with pioglitazone. Pioglitazone inhibited cell hypertrophy revealed by [(3)H]thymidine and [(3)H]proline incorporation, and pioglitazone reversed high glucose-induced G1-phase cell cycle arrest, i.e., an increase in G0/G1 phase and decrease in S and G2 phases. Pioglitazone suppressed high glucose-induced phosphorylation of p44/42 mitogen-activated protein kinase and reduced Bcl-2 and p27(Kip1) protein levels. Besides glucose-lowering action, pioglitazone ameliorates diabetic nephropathy via cell cycle-dependent mechanisms.


Assuntos
Ciclo Celular/efeitos dos fármacos , Nefropatias Diabéticas/tratamento farmacológico , Tiazolidinedionas/farmacologia , Albuminúria/tratamento farmacológico , Animais , Western Blotting , Peso Corporal/efeitos dos fármacos , Ciclo Celular/fisiologia , Linhagem Celular , Colágeno Tipo IV/metabolismo , Inibidor de Quinase Dependente de Ciclina p27/metabolismo , Nefropatias Diabéticas/metabolismo , Nefropatias Diabéticas/fisiopatologia , Glucose/farmacologia , Hipoglicemiantes/farmacologia , Imuno-Histoquímica , Insulina/farmacologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Macrófagos/patologia , Masculino , Camundongos , PPAR gama/metabolismo , Fosforilação/efeitos dos fármacos , Pioglitazona , Podócitos/citologia , Podócitos/efeitos dos fármacos , Podócitos/metabolismo , Ratos , Ratos Long-Evans , Fator de Crescimento Transformador beta1/metabolismo
7.
Appl Phys Lett ; 108(9): 093107, 2016 Feb 29.
Artigo em Inglês | MEDLINE | ID: mdl-27019515

RESUMO

In this report, we propose a direct patterning method of graphene on the SiC(0001) surface by KrF-excimer-laser irradiation. In this method, Si atoms are locally sublimated from the SiC surface in the laser-irradiated area, and direct graphene growth is induced by the rearrangement of surplus carbon on the SiC surface. Using Raman microscopy, we demonstrated the formation of graphene by laser irradiation and observed the growth process by transmission electron microscopy and conductive atomic force microscopy. When SiC was irradiated by 5000 shots of the laser beam with a fluence of 1.2 J/cm2, two layers of graphene were synthesized on the SiC(0001) surface. The number of graphene layers increased from 2 to 5-7 with an increase in the number of laser shots. Based on the results of conductive-atomic force microscopy measurements, we conclude that graphene formation was initiated from the step area, after which the graphene grew towards the terrace area by further Si evaporation and C recombination with increasing laser irradiation.

8.
Opt Lett ; 31(10): 1492-4, 2006 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-16642149

RESUMO

A novel type of waveguide quasi-phase-matched device with output electro-optical (EO) modulation is proposed and demonstrated. The second-harmonic generated output can be modulated with a high extinction ratio by integration of dual EO phase modulators on a periodically poled lithium niobate waveguide. Blue and green coherent light with EO modulation was demonstrated, and wavelength dispersion of r33 is discussed.

9.
Nanotechnology ; 17(10): 2567-73, 2006 May 28.
Artigo em Inglês | MEDLINE | ID: mdl-21727506

RESUMO

Wide-gap semiconductors with nanostructures such as nanoparticles, nanorods, nanowires are promising as a new type of UV photosensor. Recently, ZnO (zinc oxide) nanowires have been extensively investigated for electronic and optoelectronic device applications. ZnO nanowires are expected to have good UV response due to their large surface area to volume ratio, and they might enhance the performance of UV photosensors. In this paper, a new fabrication method of a UV photosensor based on ZnO nanowires using dielectrophoresis is demonstrated. Dielectrophoresis (DEP) is the electrokinetic motion of dielectrically polarized materials in non-uniform electric fields. ZnO nanowires, which were synthesized by nanoparticle-assisted pulsed-laser deposition (NAPLD) and suspended in ethanol, were trapped in the microelectrode gap where the electric field became higher. The trapped ZnO nanowires were aligned along the electric field line and bridged the electrode gap. Under UV irradiation, the conductance of the DEP-trapped ZnO nanowires exponentially increased with a time constant of a few minutes. The slow UV response of ZnO nanowires was similar to that observed with ZnO thin films and might be attributed to adsorption and photodesorption of ambient gas molecules such as O(2) or H(2)O. At higher UV intensity, the conductance response became larger. The DEP-fabricated ZnO nanowire UV photosensor could detect UV light down to 10 nW cm(-2) intensity, indicating a higher UV sensitivity than ZnO thin films or ZnO nanowires assembled by other methods.

10.
J Am Soc Nephrol ; 16(11): 3222-34, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16177004

RESUMO

Galectins are beta-galactoside-binding lectins that are involved in various biologic processes, such as apoptosis, cell proliferation, and cell-cycle regulation. Galectin-9 (Gal-9) was identified previously and demonstrated to have apoptotic potential to thymocytes in mice and activated CD8(+) T cells in nephrotoxic serum nephritis model. In this study, the effect of Gal-9 on G1-phase cell-cycle arrest, one of the hallmark pathologic changes in early diabetic nephropathy, was investigated. Eight-week-old male db/db mice received injections of recombinant Gal-9 or vehicle for 8 wk. The injection of Gal-9 into db/db mice significantly inhibited glomerular hypertrophy and mesangial matrix expansion and reduced urinary albumin excretion. Gal-9 reduced glomerular expression of TGF-beta1 and the number of p27(Kip1)- and p21(Cip1)-positive cells in glomeruli. Double staining with nephrin and type IV collagen revealed that podocytes were mainly positive for p27(Kip1). For further confirming the cell-cycle regulation by Gal-9, conditionally immortalized mouse podocyte cells were cultured under 5.5 and 25 mM d-glucose supplemented with Gal-9. Cell-cycle distribution analyses revealed that Gal-9 maintained further progression of cell cycle from the G1 phase. Gal-9 reversed the high-glucose-mediated upregulation of p27(Kip1) and p21(Cip1) and inhibited cell-cycle-dependent hypertrophy, i.e., reduced [(3)H]proline incorporation. The data suggest that Gal-9 plays a central role in inducing their successful progression from G1 to G2 phase by suppressing glomerular expression of TGF-beta1 and inhibition of cyclin-dependent kinase inhibitors. Gal-9 may give an impetus to develop new therapeutic tools targeted toward diabetic nephropathy.


Assuntos
Diabetes Mellitus Tipo 2/fisiopatologia , Galectinas/farmacologia , Glomérulos Renais/patologia , Glomérulos Renais/fisiopatologia , Podócitos/fisiologia , Animais , Técnicas de Cultura de Células , Ciclo Celular , Primers do DNA , Modelos Animais de Doenças , Galectinas/fisiologia , Glucose/farmacologia , Hipertrofia , Glomérulos Renais/efeitos dos fármacos , Masculino , Camundongos , Camundongos Mutantes , Podócitos/efeitos dos fármacos , Reação em Cadeia da Polimerase , Proteínas Recombinantes/farmacologia , Fator de Crescimento Transformador beta/genética , Fator de Crescimento Transformador beta1
11.
Proc Natl Acad Sci U S A ; 102(30): 10610-5, 2005 Jul 26.
Artigo em Inglês | MEDLINE | ID: mdl-16030142

RESUMO

There is a rapid global rise in obesity, and the link between obesity and diabetes remains somewhat obscure. We identified an adipocytokine, designated as visceral adipose tissue-derived serpin (vaspin), which is a member of serine protease inhibitor family. Vaspin cDNA was isolated by from visceral white adipose tissues (WATs) of Otsuka Long-Evans Tokushima fatty (OLETF) rat, an animal model of abdominal obesity with type 2 diabetes. Rat, mouse, and human vaspins are made up of 392, 394, and 395 amino acids, respectively; exhibit approximately 40% homology with alpha1-antitrypsin; and are related to serine protease inhibitor family. Vaspin was barely detectable in rats at 6 wk and was highly expressed in adipocytes of visceral WATs at 30 wk, the age when obesity, body weight, and insulin levels peak in OLETF rats. The tissue expression of vaspin and its serum levels decrease with worsening of diabetes and body weight loss at 50 wk. The expression and serum levels were normalized with the treatment of insulin or insulin-sensitizing agent, pioglitazone, in OLETF rats. Administration of vaspin to obese CRL:CD-1 (ICR) (ICR) mice fed with high-fat high-sucrose chow improved glucose tolerance and insulin sensitivity reflected by normalized serum glucose levels. It also led to the reversal of altered expression of genes relevant to insulin resistance, e.g., leptin, resistin, TNFalpha, glucose transporter-4, and adiponectin. In DNA chip analyses, vaspin treatment resulted in the reversal of expression in approximately 50% of the high-fat high-sucrose-induced genes in WATs. These findings indicate that vaspin exerts an insulin-sensitizing effect targeted toward WATs in states of obesity.


Assuntos
Adipócitos/metabolismo , Diabetes Mellitus Tipo 1/genética , Regulação da Expressão Gênica , Obesidade/genética , Serpinas/genética , Fatores Etários , Sequência de Aminoácidos , Animais , Sequência de Bases , Glicemia , Northern Blotting , Peso Corporal , Diabetes Mellitus Tipo 1/metabolismo , Humanos , Immunoblotting , Imuno-Histoquímica , Insulina/metabolismo , Resistência à Insulina/genética , Camundongos , Dados de Sequência Molecular , Obesidade/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos , Pioglitazona , Ratos , Ratos Endogâmicos OLETF , Análise de Sequência de DNA , Homologia de Sequência , Serpinas/metabolismo , Tiazolidinedionas
12.
J Am Soc Nephrol ; 15(12): 3215-24, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15579525

RESUMO

The molecular mechanism of anemia that is hyporesponsive to recombinant human erythropoietin (rHuEPO) in hemodialysis patients without underlying causative factors has not been investigated fully in hematopoietic stem cell system. Circulating CD34+ cells (1 x 10(4)) were isolated from rHuEPO hyporesponsive hemodialysis patients (EPO-H; n = 9), patients who were responsive to rHuEPO (EPO-R; n = 9), and healthy control subjects (n = 9). The patients with known causes of EPO hyporesponsiveness were eliminated from the current study. The cells were cultured in STEM PRO 34 liquid medium, supplemented with rHuEPO, IL-3, stem cell factor, and granulocyte-macrophage colony stimulating factor for 7 d and then transferred to a semisolid methylcellulose culture medium for performing burst forming unit-erythroid (BFU-E) colony assay. Expression of src homology domain 2 (SH2)-containing tyrosine phosphatase-1 (SHP-1), phosphorylated Janus kinase 2 (p-JAK2), and phosphorylated signal transducer and activator of transcription 5 (p-STAT5) was assessed with Western blot analysis. In EPO-H patients, SHP-1 antisense or scrambled S-oligos were included in the culture medium, and its effects were evaluated. The number of circulating CD34+ cells was not statistically different among the three groups, and their proliferation rates were similar for 7 d in culture. However, BFU-E colonies were significantly decreased in EPO-H patients compared with EPO-R and control groups. The mRNA and protein expression of SHP-1 and p-SHP-1 was significantly increased, whereas that of p-STAT5 was reduced in EPO-H patients. The inclusion of SHP-1 antisense S-oligo in culture suppressed SHP-1 protein expression associated with p-STAT5 upregulation, increase in p-STAT5-regulated genes, and partial recovery of BFU-E colonies. In EPO-H hemodialysis patients, the EPO signaling pathway is attenuated as a result of dephosphorylation of STAT5 via upregulation of SHP-1 phosphatase activity, and SHP-1 may be a novel target molecule to sensitize EPO action in these patients.


Assuntos
Anemia/tratamento farmacológico , Células Precursoras Eritroides/efeitos dos fármacos , Eritropoetina/farmacologia , Falência Renal Crônica/complicações , Proteínas Tirosina Fosfatases/metabolismo , Domínios de Homologia de src , Antígenos CD34/metabolismo , Western Blotting , Divisão Celular , Meios de Cultura/farmacologia , Proteínas de Ligação a DNA/metabolismo , Células Precursoras Eritroides/citologia , Células Precursoras Eritroides/enzimologia , Células Precursoras Eritroides/metabolismo , Vetores Genéticos , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Humanos , Técnicas In Vitro , Peptídeos e Proteínas de Sinalização Intracelular , Janus Quinase 2 , Falência Renal Crônica/terapia , Proteínas do Leite/metabolismo , Oligodesoxirribonucleotídeos Antissenso , Fosforilação , Proteína Fosfatase 1 , Proteína Tirosina Fosfatase não Receptora Tipo 6 , Proteínas Tirosina Fosfatases/genética , Proteínas Tirosina Quinases/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Recombinantes , Diálise Renal , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator de Transcrição STAT5 , Transdução de Sinais , Fator de Células-Tronco/farmacologia , Transativadores/metabolismo , Transfecção , Tirosina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA